---
title: "Rinvoq (upadacitinib) in rheumatoid arthritis: Pharmacology questions"
description: "Pharmacology questions on Rinvoq (upadacitinib) in rheumatoid arthritis, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Topics: Components, Mechanism, and Pharmacokinetics. Questions: What are the inactive ingredients in RINVOQ 15 mg tablets? How does RINVOQ work (mechanism of action)? How is RINVOQ metabolized? What is the half-life of RINVOQ? 4 questions quoted from 2 sources."
canonical: "https://www.evicenter.com/medical-information/rinvoq--rheumatoid-arthritis/pharmacology"
published: "2026-11-12T22:05:36-05:00"
modified: "2026-11-14T01:54:55-05:00"
---

# Rinvoq (upadacitinib) in rheumatoid arthritis: Pharmacology questions

Manufacturer: AbbVie Inc.  
Prescribing information: [Rinvoq](https://www.rinvoqhcp.com/prescribinginfo)

## Components

<a id="rinvoq-inactive-ingredients"></a>

### What are the inactive ingredients in RINVOQ 15 mg tablets?

> “RINVOQ 15 mg extended-release tablets for oral administration are purple, biconvex oblong, 
> with dimensions of 14 x 8 mm, and debossed with ‘a15’ on one side. Each tablet contains the 
> following inactive ingredients: colloidal silicon dioxide, ferrosoferric oxide, hypromellose, iron 
> oxide red, magnesium stearate, mannitol, microcrystalline cellulose, polyvinyl alcohol, 
> polyethylene glycol, talc, tartaric acid and titanium dioxide.”

Source: [RINVOQ: Prescribing information, page 37, captured 2026-11-08](https://www.rinvoqhcp.com/prescribinginfo#page=37)

## Mechanism

<a id="rinvoq-mechanism"></a>

### How does RINVOQ work (mechanism of action)?

> “By inactivating JAK, RINVOQ is thought to block the recruitment, phosphorylation, and activation of STATs, preventing the pro-inflammatory cytokine signal from reaching the nucleus and inhibiting pro-inflammatory processes associated with the JAK-STAT pathway.<sup>1,8,9</sup>
>
> Based on enzymatic and cellular assays, RINVOQ demonstrated greater inhibitory potency at JAK1 and JAK2 vs JAK3 and TYK2.<sup>1</sup>
>
> The relevance of inhibition of specific JAK enzymes to therapeutic effectiveness is not currently known.”

Source: [RINVOQ: RINVOQ® (upadacitinib) Mechanism of Action, captured 2026-11-08](https://www.rinvoqhcp.com/mechanism-of-action#:~:text=By%20inactivating%20JAK%2C%20RINVOQ%20is,effectiveness%20is%20not%20currently%20known.)

## Pharmacokinetics

<a id="rinvoq-metabolism"></a>

### How is RINVOQ metabolized?

> “Upadacitinib metabolism is mediated by mainly CYP3A4 with a potential minor contribution 
> from CYP2D6. The pharmacologic activity of upadacitinib is attributed to the parent molecule. 
> In a human radiolabeled study, unchanged upadacitinib accounted for 79% of the total 
> radioactivity in plasma while the main metabolite detected (product of monooxidation followed 
> by glucuronidation) accounted for 13% of the total plasma radioactivity. No active metabolites 
> have been identified for upadacitinib.”

Source: [RINVOQ: Prescribing information, page 39, captured 2026-11-08](https://www.rinvoqhcp.com/prescribinginfo#page=39)

<a id="rinvoq-half-life"></a>

### What is the half-life of RINVOQ?

> “Upadacitinib 
> mean terminal elimination half-life ranged from 8 to 14 hours.”

Source: [RINVOQ: Prescribing information, page 39, captured 2026-11-08](https://www.rinvoqhcp.com/prescribinginfo#page=39)

## Related pages
- [Medical information: Rinvoq (upadacitinib): Rheumatoid arthritis](https://www.evicenter.com/medical-information/rinvoq--rheumatoid-arthritis)
- [Indication](https://www.evicenter.com/medical-information/rinvoq--rheumatoid-arthritis/indication)
- [Clinical trials](https://www.evicenter.com/medical-information/rinvoq--rheumatoid-arthritis/clinical-trials)
- [Safety](https://www.evicenter.com/medical-information/rinvoq--rheumatoid-arthritis/safety)
- [Specific populations](https://www.evicenter.com/medical-information/rinvoq--rheumatoid-arthritis/specific-populations)
- [Drug interactions](https://www.evicenter.com/medical-information/rinvoq--rheumatoid-arthritis/drug-interactions)
- [Dosing and administration](https://www.evicenter.com/medical-information/rinvoq--rheumatoid-arthritis/dosing-and-administration)
- [Storage and supply](https://www.evicenter.com/medical-information/rinvoq--rheumatoid-arthritis/storage-and-supply)
- [Access and coverage](https://www.evicenter.com/medical-information/rinvoq--rheumatoid-arthritis/access-and-coverage)
